Ethical reflections on phase I clinical trials of anticancer drugs: from a Chinese IRB's empirical perspective.
| Publicado en: | Holistic Integrative Oncology Vol. 3; no. 1; pp. 1 - 9 |
|---|---|
| Autores principales: | , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Springer Nature
11/27/2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=181200614&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 181200614 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 27314529 N50T jtl: Holistic Integrative Oncology issn: 27314529 maglogo: N pubinfo: dt: 11/27/2024 vid: 3 iid: 1 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 181200614 181200614 181200614 10.1007/s44178-024-00126-4 181200614 ppf: 1 ppct: 8 formats: tig: atl: Ethical reflections on phase I clinical trials of anticancer drugs: from a Chinese IRB's empirical perspective. aug: au: Liu, Xiaoling Song, Zhengbo Tang, Shuting Wang, Zhaochen Zhu, Ji affil: https://ror.org/0144s0951 The Medical Ethics Office, Zhejiang Cancer Hospital, Hangzhou, China sug: subj: Antineoplastic Agents Therapeutic Use Drug Development Drugs, Investigational Ethical Issues Clinical Trials Ethical Issues Protection of Human Subjects Human Male Female China Academic Medical Centers Retrospective Design Record Review Stakeholder Participation Research Subjects Consent Safety Protocols Funding Source Institutional Review Male Female pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|